COR Q4 Earnings & Revenues Beat Estimates, Gross Margin Improves

Key Takeaways COR reported Q4 EPS of $3.84, beating estimates by 2.7%, on revenues of $83.73B, up 5.9% year over year.COR's U.S. Healthcare sales rose 5.7%, driven by GLP-1 and specialty product, lifting segment profit 25%.COR guided FY26 EPS to $17.45-$17.75, with 5-7% revenue growth and 8-10% operating income expansion.Cencora, Inc. (COR) reported fourth-quarter fiscal 2025 adjusted earnings per share (EPS) of $3.84, which beat the Zacks Consensus Estimate of $3.74 by 2.7%. The bottom line also improved 1 ...